You are here

  • Home
  • Archive
  • Volume 11, Issue Suppl 2
  • 629-D The anti-tumor activity of IFNβ and membrane-stable CD40L expressing oncolytic virus MEM-288 in NSCLC patients is associated with modulation of the tumor microenvironment and systemic immune response

Citation Tools

Article menu

Download PDFPDF

Regular Abstracts – Part 2
Clinical Trial Completed
629-D The anti-tumor activity of IFNβ and membrane-stable CD40L expressing oncolytic virus MEM-288 in NSCLC patients is associated with modulation of the tumor microenvironment and systemic immune response

Download to a citation manager

Download the citation for this article by clicking on one of the following citation managers:

Cite this article as:
Saltos AN, Arrowood C, Beasley GM, et al
629-D The anti-tumor activity of IFNβ and membrane-stable CD40L expressing oncolytic virus MEM-288 in NSCLC patients is associated with modulation of the tumor microenvironment and systemic immune response
Journal for ImmunoTherapy of Cancer 2023;11:doi: 10.1136/jitc-2023-SITC2023.0629-D